Table 1 Presence of WHO ethical criteria in the brochures (N = 60)
From: Pharmaceutical brochures in Lebanon: do they meet WHO recommendations?
WHO ethical criteria | Total N = 60 (100%) | National companies N = 11 (18.3%) | Multinational companies N = 45 (75%) | P-Value |
|---|---|---|---|---|
Name of active ingredient | 59 (98.3%) | 11 (100%) | 44 (97.7%) | 0.618 |
Brand name | 60 (100%) | 11 (100%) | 45 (100%) | – |
Content of active ingredient | 47 (78.3%) | 8 (72.7%) | 36 (80%) | 0.598 |
Other ingredients | 22 (36.7%) | 5 (45.4%) | 15 (33.3%) | 0.452 |
Therapeutic uses | 47 (78.3%) | 10 (90.9%) | 33 (73.3%) | 0.216 |
Dose | 41 (68.3%) | 8 (72.7%) | 30 (66.6%) | 0.700 |
Side effects | 26 (43.3%) | 5 (45.4%) | 19 (42.2%) | 0.846 |
Precautions, contraindications | 24 (40%) | 3 (27.2%) | 19 (42.2%) | 0.363 |
Major interactions | 20 (33.3%) | 2 (18.1%) | 17 (37.7%) | 0.219 |
Name and address of the manufacturer | 32 (53.3%) | 7 (63.6%) | 23 (51.1%) | 0.498 |
Reference to literature | 30 (50%) | 4 (36.3%) | 23 (51.1%) | 0.380 |